Effects of eight weeks' continuous treatment with oral ranitidine and cimetidine on gastric acid secretion, pepsin secretion, and fasting serum gastrin.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Gut

• Publication date

  1983-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/gut.24.1.61PMID 6129180PMCID PMC1419923
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Investigations on the length of action of ranitidine (author's transl)].

  2008cited by this paper
• Ranitidine--a new H2-receptor antagonist.

  1980cited by this paper
• Comparison of ranitidine and cimetidine in the inhibition of histamine, sham-feeding, and meal-induced gastric secretion in duodenal ulcer patients.

  1980cited by this paper
• Pharmacologically effective plasma concentrations of ranitidine.

  1979cited by this paper
• Pharmacologically effective plasma concentrations of ranitidine.

  1979cited by this paper
• Inhibition of pentagastrin-stimulated and nocturnal gastric secretion by ranitidine. A new H2-receptor antagonist.

  1979cited by this paper
• Ranitidine (AH 19065): a new potent, selective histamine H2-receptor antagonist [proceedings].

  1979cited by this paper
• Histamine H2-receptor antagonists.

  1978cited by this paper
• The effect of cimetidine, a new histamine H2-receptor antagonist, on meal-stimulated acid secretion, serum gastrin, and gastric emptying in patients with duodenal ulcer.

  1976cited by this paper
• Effect of cimetidine on 24-hour intragastric acidity in normal subjects.

  1976cited by this paper
• Heptadecapeptide gastrin: measurement in blood by specific radioimmunoassay.

  1976cited by this paper
• Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man.

  1975cited by this paper
• Gastric-acid output, pepsin output, and lean body mass in normal and duodenal-ulcer subjects.

  1975cited by this paper
• CYTOPHILIC AUTOANTIBODY IN CHRONIC ACTIVE HEPATITIS

  1975cited by this paper
• 24-hour control of intragastric acidity by cimetidine in duodenal-ulcer patients.

  1975cited by this paper
• Proceedings: The 24-hour control of intragastric pH by cimetidine, a new H2-receptor antagonist, in normal subjects and in patients with duodenal ulcer.

  1975cited by this paper
• The effect of histamine H2-receptor blockade with metiamide on serum gastrin levels in man.

  1975cited by this paper
• Gastric alkalinization. Effect on lower-esophageal-sphincter pressure and serum gastrin.

  1974cited by this paper
• Parietal cell hyperplasia induced by the administration of pentagastrin (ICI 50,123) to rats.

  1969cited by this paper
• Pentagastrin as a stimulant of maximal gastric acid response in man. A multicentre pilot study.

  1967cited by this paper
• The estimation of peptic activity in gastric juice using radioiodinated serum albumin as substrate.

  1960cited by this paper
• Effect of large doses of histamine on gastric secretion of HCI; an augmented histamine test.

  1953cited by this paper
• Effect of Large Doses of Histamine on Gastric Secretion of HCl

  1953cited by this paper

• Histamine receptor 2 blockade selectively impacts B and T cells in healthy subjects

  2021cites this paper
• Impact of acid-reducing agents on gastrointestinal physiology and design of biorelevant dissolution tests to reflect these changes.

  2019cites this paper
• Study to determine the likely accuracy of pH testing to confirm nasogastric tube placement

  2018cites this paper
• Diagnostic accuracy of a pH stick, modified to detect gastric lipase, to confirm the correct placement of nasogastric tubes

  2018cites this paper
• To those who demand scientific evidence for homeopathy

  2017cites this paper
• Comparison of effect of an increased dosage of vonoprazan versus vonoprazan plus lafutidine on gastric acid inhibition and serum gastrin

  2017cites this paper
• Aos que clamam pelas evidências científicas em homeopatia

  2017cites this paper
• Scientific basis of the homeopathic healing principle in modern pharmacology

  2017cites this paper
• Similia similibus curentur: o princípio de cura homeopático fundamentado na farmacologia moderna

  2013cites this paper
• The Significance of Gastrin in the Pathogenesis and Therapy of Peptic Ulcer Disease

  2012cites this paper
• Rebound effect of drugs: fatal risk of conventional treatment and pharmacological basis of homeopathic treatment

  2012cites this paper
• Normal dogs treated with famotidine for 14 days have only transient increases in serum gastrin concentrations.

  2011cites this paper
• Rebound acid hypersecretion after withdrawal of gastric acid suppressing drugs: new evidence of similitude

  2011cites this paper
• Helicobacter pylori and tolerance to H2‐blockers

  2005cites this paper
• Comparison of verapamil and cimetidine for their effects on volume and acidity of Carbachol induced gastric secretion in fasting rabbits.

  2005cites this paper
• Stability of Gastric-JuicePepsin , and a Methodfor its Preservation

  2004cites this paper
• Effect of gastrointestinal motility and feeding tube site on aspiration risk in critically ill patients: a review.

  2004cites this paper
• Helicobacter pylori eradication releases prolonged increased acid secretion following omeprazole treatment.

  2004cites this paper
• Plasma prolactin, sex steroids and gastrin in human volunteers treated for 2 weeks with therapeutic doses of cimetidine or the new histamine H2-receptor antagonist ramixotidine (CM 57755A)

  2004cites this paper
• Comparison between the effects of extract from the seeds of myristica fragrans and cimetidine on the volume and acidity of carbachol induced gastric secretion in fasting rabbits

  2004cites this paper
• Problems related to acid rebound and tachyphylaxis.

  2001cites this paper
• Rebound acid hypersecretion after acid-suppressive therapy

  2000cites this paper
• Marked rebound acid hypersecretion after treatment with ranitidine.

  1996cites this paper
• Pharmacokinetics and pharmacodynamics of roxatidine in patients with renal insufficiency.

  1995cites this paper
• [Sensitivity of gastric parietal cells to histamine after administration of enprostil and ranitidine during 4 weeks in healthy subjects].

  1994cites this paper
• Influence of Gastric pH Modifiers on Development of Intestinal Metaplasia Induced by X‐Irradiation in Rats

  1993cites this paper
• Tolerance during Dosing with H2-Receptor Antagonists

  1992cites this paper
• Effect of duodenal ulcer healing induced by omeprazole and ranitidine on the generation of gastroduodenal eicosanoids, platelet-activating factor, pepsinogen A, and gastrin in duodenal ulcer patients.

  1992cites this paper
• Gastric acid secretion and plasma gastrin during short-term treatment with omeprazole and ranitidine in duodenal ulcer patients.

  1992cites this paper
• The effect of H2‐blockade on plasma gastrin concentration in patients with an achlorhydric stomach

  1992cites this paper
• Effects of successive doses of nizatidine, cimetidine and ranitidine on serum gastrin level and gastric acid secretion.

  1991cites this paper
• Reversible sustained increase of gastrin and gastric acid secretion in a subgroup of duodenal ulcer patients on long-term treatment with H2 antagonists.

  1991cites this paper
• Much ado about gastrin.

  1991cites this paper
• Composition of gastro-oesophageal refluxate.

  1991cites this paper
• Tolerance and rebound to H2-receptor antagonists: Intragastric acidity in patients with duodenal ulcer

  1991cites this paper
• Omeprazole 20 mg three days a week and 10 mg daily in prevention of duodenal ulcer relapse. Double-blind comparative trial.

  1991cites this paper
• Hypergastrinemia is associated with decreased gastric acid secretion in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated rats.

  1990cites this paper
• Gastric histology and plasma gastrin response to a meal in patients with duodenal ulcer disease after five years treatment with ranitidine

  1990cites this paper
• Effects of partial resection of acid-secreting mucosa on plasma gastrin and enterochromaffin-like cells in the rat stomach.

  1990cites this paper
• Combined gastric and oesophageal 24‐hour pH monitoring and oesophageal manometry in patients with reflux disease, resistant to treatment with omeprazole.

  1990cites this paper
• Drug-induced changes of plasma gastrin concentration.

  1990cites this paper
• Temporary cessation of long-term maintenance treatment with omeprazole in patients with H2-receptor-antagonist-resistant reflux oesophagitis. Effects on symptoms, endoscopy, serum gastrin, and gastric acid output.

  1990cites this paper
• Effects of omeprazole on gastric secretory functions.

  1989cites this paper
• A single night‐time dose of famotidine is equivalent to ranitidine in decreasing 24‐hour gastric acidity in asymptomatic duodenal ulcer subjects

  1989cites this paper
• Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist.

  1989cites this paper
• Initial therapy and relapse of duodenal ulcer: possible acid secretory mechanisms.

  1989cites this paper
• Zollinger-Ellison syndrome in a patient with normal screening gastrin level

  1989cites this paper
• Mechanisms of relapse in peptic ulcer disease.

  1989cites this paper
• Inhibition of Gastric Acid Secretion

  1989cites this paper
• Colloidal bismuth in the treatment of duodenal ulceration: the benefit for the patient.

  1989cites this paper
• The potential impact of Campylobacter pylori on the treatment of duodenal ulcer disease.

  1989cites this paper
• Increased parietal cell sensitivity after chronic treatment with ranitidine in the conscious cat

  1989cites this paper
• The effects of famotidine, 40 mg at night, on 24-hour intragastric acidity and plasma gastrin concentration in healthy subjects.

  1988cites this paper
• Effect of low‐dose omeprazole on gastric acid secretion in duodenal ulcer patients

  1988cites this paper
• Dose-response, meal-stimulated gastric antisecretory study of prostaglandin E1 analog, misoprostol, in man

  1988cites this paper
• THE EFFECTS OF RANITIDINE and CYSTEAMINE ON INTESTINAL METAPLASIA INDUCED BY X‐IRRADIATION IN RATS

  1988cites this paper
• Review: the enterochromaffin‐like cell, intragastric acidity and the trophic effect of plasma gastrin

  1988cites this paper
• Effect of intermittent weekend therapy with omeprazole on basal and postprandial serum gastrin concentrations in patients with duodenal ulcer

  1988cites this paper
• Hormonal regulation of gastric acid in peptic ulcer disease.

  1988cites this paper
• Effects of omeprazole and ranitidine on gastric acid secretion, blood gastrin levels and [3H]-thymidine incorporation in the oxyntic mucosa from dogs and rats.

  1988cites this paper
• Influence of ulcer healing agents on ulcer relapse after discontinuation of acute treatment: a pooled estimate of controlled clinical trials.

  1988cites this paper
• Prostaglandins for duodenal ulcer.

  1987cites this paper
• Twenty‐four‐hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole

  1987cites this paper
• Perspective on the gastric antisecretory effects of misoprostol in man.

  1987cites this paper
• The effects of substance P, histamine and histamine antagonists on somatostatin and gastrin release from the isolated perfused rat stomach.

  1987cites this paper
• Twenty-four hour intragastric acidity during treatment with oral omeprazole.

  1986cites this paper
• Relapse of duodenal ulcer: does it matter which drug is used in initial treatment?

  1986cites this paper
• Augmented postprandial gastric acid secretion due to exposure to ranitidine in healthy subjects.

  1986cites this paper
• [Effectiveness of cimetidine and ranitidine in peptic ulcer].

  1986cites this paper
• Prostaglandins for duodenal ulcer and gastric ulcer

  1986cites this paper
• Gastric regulatory peptides in rats with reduced acid secretion.

  1986cites this paper
• Effect of inhibition of acid secretion on the regulatory peptides in the rat stomach.

  1986cites this paper
• Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum gastrin and serum pepsinogen I levels

  1986cites this paper
• Effect of misoprostol, an antiulcer prostaglandin, on serum gastrin in patients with duodenal ulcer

  1986cites this paper
• Effects of changes in intragastric pH resulting from alterations in meal viscosity on serum gastrin levels in duodenal ulcer patients.

  1985cites this paper
• Ranitidine hydrochloride-induced hypergastrinemia.

  1985cites this paper
• [Cimetidine and rebound].

  1985cites this paper
• Effects of eight-week treatment with oral ranitidine on plasma level changes of gastrin, histamine and serotonin in duodenal ulcer patients.

  1985cites this paper
• The antisecretory effects of RP 40 749 in patients with previous duodenal ulcer.

  1985cites this paper
• Stability of Gastric-Juice Pepsin, anda Method for itsPreservation

  1984cites this paper
• Stability of gastric-juice pepsin, and a method for its preservation.

  1984cites this paper
• Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity.

  1984cites this paper
• Effect of single dose of omeprazole on the gastrointestinal peptide response to food.

  1984cites this paper
• Ranitidine Hydrochloride

  1983cites this paper